Skip to Content

2 mg ETH267 (Doxazosin 2 mg)

Pill imprint 2 mg ETH267 has been identified as Doxazosin mesylate 2 mg.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Doxazosin mesylate 2 mg 2 mg ETH267 Front
Doxazosin mesylate 2 mg 2 mg ETH267 Back
Doxazosin mesylate 2 mg 2 mg ETH267
Doxazosin mesylate
2 mg
2 mg
Elliptical / Oval
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Ethex Corporation
National Drug Code (NDC):
Inactive Ingredients:
hydrated alumina
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67253-0381 DAVA Pharmaceuticals, Inc.
54569-5169 A-S Medication Solutions, LLC (repackager)
58016-0997 Southwood Pharmaceuticals Inc (repackager)
33358-0116 CorePharma, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.